Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Horowski

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Journal of Endocrinological Investigation|April 1, 1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyD Dallabonzana, A Liuzzi, G Oppizzi, et al.
British Journal of Obstetrics and Gynaecology|November 1, 1979
Effect of lisuride on inhibition of lactation and serum prolactinL De Cecco, P L Venturini, N Ragni, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1993
[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]J Hierholzer, M Cordes, L Schelosky, et al.
European Journal of Pharmacology|March 3, 1992
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsK W Lange, P A Löschmann, H Wachtel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative tergurideD Dallabonzana, A Liuzzi, G Oppizzi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 1, 1981
Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind studyP L Venturini, R Horowski, C Maganza, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1992
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]J Hierholzer, M Cordes, L Schelosky, et al.
Advances in Neurology|January 1, 1993
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controlsM Cordes, J Hierholzer, L Schelosky, et al.
Clinical Neuropharmacology|February 1, 1996
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placeboE Martignoni, R Horowski, A Liuzzi, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic womenP L Venturini, R Horowski, M Valenzano, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Journal of Endocrinological Investigation|April 1, 1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyD Dallabonzana, A Liuzzi, G Oppizzi, et al.
British Journal of Obstetrics and Gynaecology|November 1, 1979
Effect of lisuride on inhibition of lactation and serum prolactinL De Cecco, P L Venturini, N Ragni, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1993
[The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test]J Hierholzer, M Cordes, L Schelosky, et al.
European Journal of Pharmacology|March 3, 1992
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsK W Lange, P A Löschmann, H Wachtel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative tergurideD Dallabonzana, A Liuzzi, G Oppizzi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 1, 1981
Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind studyP L Venturini, R Horowski, C Maganza, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1992
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients]J Hierholzer, M Cordes, L Schelosky, et al.
Advances in Neurology|January 1, 1993
IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controlsM Cordes, J Hierholzer, L Schelosky, et al.
Clinical Neuropharmacology|February 1, 1996
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placeboE Martignoni, R Horowski, A Liuzzi, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic womenP L Venturini, R Horowski, M Valenzano, et al.
Pageof 8